The Latitude trial found monthly injections nearly halve treatment failure compared to daily pills, addressing stigma and ...

Health experts are raising concerns over the increasing number of tuberculosis and HIV co-infections in Fiji, describing the ...

For thousands of Nigerians who face a daily struggle to stay protected from HIV, the arrival of Lenacapavir, a long-acting injection taken just twice a year, signals a new chapter in prevention.For ...

The Federal Government on Tuesday said it aims to commence self-financing for HIV and tuberculosis programmes as it plans to end donor dependence.This was disclosed by the Coordinating Minister of ...

HIV cases continue to rise, prompting the Ministry of Health to look at expanding access to a wider range of HIV medications.

There are various reasons for medication failure,” says Majaha Mtshali, tuberculosis (TB) focal person and staff nurse at ...

Researchers have identified a promising antiviral compound that blocks hepatitis E replication in early studies. Because it ...

For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily ...

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...

The Federal Government has cautioned Nigerians not to misinterpret Lenacapavir (Len PrEP), the breakthrough twice-yearly injectable drug for the prevention of HIV, as a free pass for risky sexual ...